News

A new therapy for treating Type 1 diabetes

October 20, 2021

Promising early results show that longstanding Harvard Stem Cell Institute (HSCI) research may have paved the way for a breakthrough treatment of Type 1 diabetes. Utilizing research from the Melton Lab, Vertex Pharmaceuticals has developed VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes (T1D). In conjunction with immunosuppressive therapy, VX-880 produced robust restoration of islet cell function on Day 90 in the first patient in its Phase 1/2 clinical trial.... Read more about A new therapy for treating Type 1 diabetes

Call for Proposals: 2021 HSCI Musculoskeletal Disease Program Pilot Grants

October 8, 2021

CALL FOR PROPOSALS

2021 HSCI MUSCULOSKELETAL DISEASE PROGRAM PILOT GRANTS

 

AWARD AMOUNT
Up to $100,000 for entire project period
Project period not to exceed two years

POSTED DATE
Friday, October 8, 2021
DEADLINE FOR APPLICATION
Friday, November 12, 2021
ANTICIPATED AWARD DATE
January 1, 2022

 

The Harvard Stem Cell Institute (HSCI) Musculoskeletal (MSK) Disease Program invites applications for pilot grant funding. The purpose of this program is to provide funding for innovative projects in the field of musculoskeletal stem cell and regenerative biology. HSCI strongly encourages proposals with a translational focus, or which are otherwise poised to accelerate the development of new stem cell-based therapies or cures for musculoskeletal injuries or disease. However, proposals at all stages of development are welcome, as are proposals that encompass a collaboration between two MSK labs where at least one of the labs is member of the HSCI. The HSCI MSK Program intends to award up to two grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI MSK Disease Program funds.... Read more about Call for Proposals: 2021 HSCI Musculoskeletal Disease Program Pilot Grants

Call for Proposals: 2021 Fall HSCI Collaborative Seed Grants

June 21, 2021

CALL FOR PROPOSALS

FALL 2021 HSCI COLLABORATIVE SEED GRANTS

 

AWARD AMOUNT
$100,000 per project per year for up to two years
POSTED DATE
Monday, June 21, 2021
DEADLINE FOR APPLICATION
Friday, September 17, 2021
ANTICIPATED AWARD DATE
Monday, November 1, 2021

 

The Harvard Stem Cell Institute (HSCI) invites applications for seed grant funding for its Fall 2021 cycle.

The purpose of this program is to provide funding for innovative projects in the field of stem cell and regenerative biology that are a collaboration between two labs. HSCI strongly encourages proposals with a translational focus, or which are otherwise poised to accelerate the development of new stem cell-based therapies or cures. However, proposals at all stages of development are welcome. The HSCI intends to award up to five grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI funds.... Read more about Call for Proposals: 2021 Fall HSCI Collaborative Seed Grants